XML 53 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Earnings Per Share (Details) - shares
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted weighted shares outstanding 3,212,377 1,399,242
Lucid Diagnostics Inc. 2018 Equity Plan: Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted weighted shares outstanding 975,942 975,942
Lucid Diagnostics Inc. 2018 Equity Plan: Unvested Restricted Stock Awards [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted weighted shares outstanding 1,813,135
Stock Options Not Granted Under Plan [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted weighted shares outstanding 423,300 423,300